Back

Menu
Vaxxitek-IBD

Vaxxitek® HVT+IBD
The Innovative Leader

Just one shot at the hatchery provides 2-in-1 protection against infectious bursal disease (IBD) and Marek’s disease (MD) in broiler, layer, and breeder chickens.

Contact us

VAXXITEK® HVT+IBD

The Innovative Leader

  • Vaxxitek Amps

    2-in-1 Protection

    Just one shot at the hatchery provides 2-in-1 protection against infectious bursal disease (IBD) and Marek’s disease (MD) in broiler, layer, and breeder chickens.

  • Chicken

    Immune Foundation

    Helps lay a strong immune foundation for flock health.2–9

  • Virus

    Broad IBDV Protection

    Protects against all tested strains of IBDV—classic, very virulent, and variant.

  • Chick

    Proven Early Onset

    Can be given at the hatchery to achieve early protection and avoid the immunity gap.1

HOW IT WORKS

  • 1-Early replication

    VAXXITEK® HVT+IBD starts to colonize targeted lymphocyte populations between one and two weeks of age.

  • 2-Express IBD protein

    During replication, IBD viral VP2 protein is expressed.

  • 3-Induce immunity

    HVT and VP2 induce an immune response that protects chickens against both IBD and MD.

SEE VAXXITEK® HVT+IBD IN ACTION

Vaxxitek-IBD

VAXXITEK® HBT+IBD PRODUCT INFORMATION

Indication

  • Recommended for the vaccination of healthy 18- to 19-day-old chicken embryos and one-day-old chickens against standard and variant bursal disease and Marek’s disease

Dosage

  • Available in 1000, 2000, 4000 dose ampules in frozen presentation

Safety Information

  • Do not mix with other products, except as specified on the label
  • In case of human exposure, contact a physician
  • Administer only as recommended
  • Use entire contents when first opened
  • Do not vaccinate within 21 days before slaughter
  • Contains amphotericin B as a fungistatic agent
  • Inactivate unused contents before disposal
Download PDF

References: 1. Le Gros F-X, Dancer A, Giacomini C, et al. Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers. Vaccine. 2009;27:592–596. 2. Hoerr FJ. Clinical Aspects of immunosuppression in poultry. Avian Dis. 2010; 54:2–15. 3. Naqi S, Thompson G, Bauman B, Mohammed H. The exacerbating effect of infectious bronchitis virus infection on the infectious bursal disease virus-induced suppression of opsonization by Escherichia coli antibody in chickens. Avian Dis. 2001; 45:52–60. 4. Alonso Castro M, Merino Cabria D, Fernandez Garcia D, et al. Evaluation of the effects of vaccination with a HVT-IBD vector vaccine on bursa Fabricii, production parameters and meat properties in broilers. Abstract presented at the XVIII Congress of the World Veterinary Poultry Association; 2013: Nantes, France. 5. Devaud I, Herin JB, Trotel A, Pagot E, Voisin F. A field study in commercial layers to evaluate the effects of an HVT-IBD vector vaccine on production performances in comparison with a live IBD vaccine. Abstract presented at the XVIII Congress of the World Veterinary Poultry Association; 2013: Nantes, France. 6. Ganapathy K, Wilkins M, Forrester A, Jones RC, Lemiere S. Protection and immune responses against virulent infectious bronchitis viruses in HVT-IBD recombinant or IBD-complex vaccinated broiler chicks. Abstract presented at the First International Respiratory Disease Conference, Athens, United States of America, 2011. 7. Lemiere S, Wilkins M, Forrester A, Jones R, Ganapathy K. Protection and immune responses against virulent infectious bronchitis (IB) viruses in herpesvirus turkey-infectious bursal disease (HVT-IBD) vaccinated broiler chicks. Poster presentation. Abstract presented at the XVII Congress of the World Veterinary Poultry Association; 2011: Cancun, Mexico. 8. Rautenschlein S, Lemiere S, Prandini F. Evaluation of the effects of an HVT-IBD vector vaccine on the immune system of layer pullets in comparison with two commercial live IBD vaccines. Abstract presented at the XVIII Congress of the World Veterinary Poultry Association; 2013: Nantes, France. 9. Rautenschlein S, Lemiere S, Simon B, Prandini F. A comparison of the effects on the humoral and cell-mediated immunity between an HVT-IBD vector vaccine and an IBDV immune complex vaccine after in ovo vaccination of commercial broilers. Abstract presented at the XVIII Congress of the World Veterinary Poultry Association; 2013: Nantes, France. 10. Garritty AT. The effect of vectored HVT+IBD (Vaxxitek® HVT+IBD) vaccination on body weights, uniformity and virus shedding in commercial broilers. Abstract presented at the International Poultry Scientific Forum; 2011: Atlanta, Georgia. 11. Fernandez R, Rojo F, Garcia H, Sanchez P, Martinez H, Menendez A, Ruiz H et al. Field efficacy in broiler chickens in Latin America of vHVT-013, a Marek’s HVT vector vaccine expressing VP2 in infectious bursal disease virus. Abstract presented at the XVI Congress of the World Veterinary Poultry Association; 2007: Strasbourg, France. 12. Atienza JC, Nagera AJ, Martinez PO, et al. Evaluation of a herpesvirus of turkey vector vaccine inducing protection against infectious bursal and Marek’s diseases (VAXXITEK® HVT+IBD) under Philippines field conditions. Abstract presented at: The XVIII Congress of the World Veterinary Poultry Association; 2008: Brisbane, Australia. 13. Bublot M. Vector vaccines for poultry: their advantages and limitations compared to classical vaccines. Proceedings of the International Symposium on Poultry Diseases, December 14–15, 2015. 

WELCOME TO VAXXITEK.COM

This website is intended to be an international resource for general purpose information. Accordingly, the content provided is international in nature and is for veterinarians only.

Please be aware that country-specific information may be more relevant to you, which in some cases may differ from the general information provided on this website.

I am a veterinarian I am NOT a veterinarian